Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Fondaparinux for the prevention or treatment of venous thromboembolism related to lower limb trauma: evidence today.

Kanakaris NK, Nikolaou VS, Tosounidis T, Giannoudis PV.

Curr Vasc Pharmacol. 2008 Apr;6(2):134-42. Review.

PMID:
18393915
2.

Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.

Nijkeuter M, Huisman MV.

Curr Opin Pulm Med. 2004 Sep;10(5):338-44. Review.

PMID:
15316429
3.

Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.

Shorr AF, Sarnes MW, Peeples PJ, Stanford RH, Happe LE, Farrelly E.

Am J Health Syst Pharm. 2007 Nov 15;64(22):2349-55.

PMID:
17989444
4.

Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.

Lu JP, Knudson MM, Bir N, Kallet R, Atkinson K.

J Am Coll Surg. 2009 Nov;209(5):589-94. doi: 10.1016/j.jamcollsurg.2009.08.001. Epub 2009 Sep 11.

PMID:
19854398
5.

Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data.

Lobo BL.

Pharmacotherapy. 2004 Jul;24(7 Pt 2):66S-72S. Review.

PMID:
15317401
6.

Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.

Farias-Eisner R, Horblyuk R, Franklin M, Lunacsek OE, Happe LE.

Curr Med Res Opin. 2009 May;25(5):1081-7. doi: 10.1185/03007990902837117 .

PMID:
19298219
8.
9.

Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis.

Bjorvatn A, Kristiansen F.

Am J Cardiovasc Drugs. 2005;5(2):121-30.

PMID:
15725043
10.

Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.

Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N.

Thromb Res. 2007;121(1):17-24. Epub 2007 Apr 20.

PMID:
17449088
11.

The safety of fondaparinux for the prevention and treatment of venous thromboembolism.

Turpie AG.

Expert Opin Drug Saf. 2005 Jul;4(4):707-21. Review.

PMID:
16011449
12.

Prevention of venous thromboembolism in the orthopedic surgery patient.

Deitelzweig SB, McKean SC, Amin AN, Brotman DJ, Jaffer AK, Spyropoulos AC.

Cleve Clin J Med. 2008 Apr;75 Suppl 3:S27-36. Review.

PMID:
18494224
13.

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.

Turpie AG.

Expert Opin Pharmacother. 2004 Jun;5(6):1373-84. Review.

PMID:
15163281
14.

Fondaparinux.

Tan KT, Lip GY.

Curr Pharm Des. 2005;11(4):415-9. Review.

PMID:
15725062
15.

Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.

van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, B├╝ller HR.

Thromb Haemost. 2009 Apr;101(4):762-9.

PMID:
19350123
16.

The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study.

Singelyn FJ, Verheyen CC, Piovella F, Van Aken HK, Rosencher N; EXPERT Study Investigators.

Anesth Analg. 2007 Dec;105(6):1540-7, table of contents.

PMID:
18042845
17.

Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients.

Dranitsaris G, Kahn SR, Stumpo C, Paton TW, Martineau J, Smith R, Ginsberg JS; Fondaparinux Canadian Health Economic Study Investigators.

Am J Cardiovasc Drugs. 2004;4(5):325-33.

PMID:
15449974
18.

Factor Xa inhibitors in acute coronary syndromes and venous thromboembolism.

Yong CM, Boyle AJ.

Curr Vasc Pharmacol. 2010 Jan;8(1):5-11. Review.

PMID:
19485937
19.

[Venous thromboembolism prophylaxis in orthopaedics and traumatology].

Kessler P.

Vnitr Lek. 2009 Mar;55(3):204-10. Review. Czech.

PMID:
19378847
20.

Supplemental Content

Support Center